Jones Jeffrey Alan 4
4 · Cullinan Therapeutics, Inc. · Filed Dec 19, 2025
Insider Transaction Report
Form 4
Jones Jeffrey Alan
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-12-18$9.67/sh−4,632$44,791→ 169,532 total
Footnotes (1)
- [F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.